Sotabase

Career

· Research Scientist, MIT Julia Lab2020–
· PhD Student, MIT Julia Lab2018–
· Research Intern, MIT Julia Lab2017–
· Research Assistant, MIT Julia Lab2016–

Publications (85)

Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems
Supportive Care in Cancer · 2013
158
cited
Pain outcomes in patients with advanced breast cancer and bone metastases
Cancer · 2013
144
cited
The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain
European Journal of Cancer Care · 2010
132
cited
Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid
Clinical Cancer Research · 2012
130
cited
Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma
JAMA Network Open · 2020
94
cited
Estimating minimally important differences for the worst pain rating of the Brief Pain Inventory-Short Form.
The Journal of Supportive Oncology · 2011
91
cited
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid
Supportive Care in Cancer · 2013
84
cited
Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases
Prostate Cancer and Prostatic Diseases · 2012
63
cited
Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study
Acta oncologica · 2014
61
cited
Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States
Journal of Medical Economics · 2012
60
cited
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid.
Annals of Oncology · 2012
42
cited
Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer
Radiation Oncology · 2012
40
cited
Healthcare resource utilization and costs in patients with newly diagnosed acute myeloid leukemia
Journal of Medical Economics · 2018
39
cited
Assessing analgesic use in patients with advanced cancer: development of a new scale--the Analgesic Quantification Algorithm.
Pain medicine (Malden, Mass.) · 2014
38
cited
Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems
Supportive Care in Cancer · 2014
34
cited
Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases
Patient Preference and Adherence · 2013
30
cited
Treatment patterns in patients with prostate cancer and bone metastasis among US community-based urology group practices.
Urology · 2012
28
cited
Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases
Journal of Medical Economics · 2014
27
cited
Health state utilities for skeletal-related events secondary to bone metastases
European Journal of Health Economics · 2013
25
cited
Health resource utilisation associated with skeletal‐related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study
European Journal of Cancer Care · 2017
23
cited
Sotabase